Tag: food and drug administration

May 22, 2018

5 Top Weekly NASDAQ Biotech Stocks: Eiger BioPharmaceuticals Leads with 81.62 Percent

Eiger BioPharmaceuticals, Arqule, Galectin Therapeutics, MEI Pharma and BioDelivery Sciences were last week's top gainers on the NASDAQ.
May 20, 2018

Cannabis Weekly Round-Up: Aurora Wants to Buy MedReleaf for C$3.2 Billion

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
May 13, 2018

5 Top Weekly NASDAQ Biotech Stocks: Helius Up 43.19 Percent

Helius Medical Technologies, vTv Therapeutics, Second Sight Medical Products, Depomed and Senomyx were last week's top gainers on the NASDAQ.
May 10, 2018

Medicenna Receives Amendment to Revamp Clinical Trial

The Investing News Network had the opportunity to speak with Medicenna CEO Fahar Merchant at the Bloom Burton & Co....
May 10, 2018

MediciNova Announces Opening of Investigational New Drug Application for MN-166 (ibudilast) in Glioblastoma

MediciNova a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange...
May 10, 2018

Cellectar Granted Orphan Drug Designation for CLR 131 to Treat Rhabdomyosarcoma

Cellectar Biosciences (Nasdaq:CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of...
May 10, 2018

Koios Subsidiary, Cannavated, To Develop Line Of Cannabis Functional Beverages

Koios Beverage Corp. (CSE: KBEV; OTC: SNOVF) (the "Company" or "Koios"), is pleased to announce the creation of Cannavated Beverage...
May 9, 2018

Supernus Announces First Quarter 2018 Financial Results and Record Quarterly Revenue

Supernus Pharmaceuticals (NASDAQ:SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system...
May 9, 2018

OpGen Reports First Quarter 2018 Financial Results and Provides a Business Update

OpGen (NASDAQ:OPGN) today reported financial and operating results for the three months ended March 31, 2018, and provided a summary...
May 9, 2018

Opiant Pharmaceuticals, Inc. Reports First Quarter 2018 Financial Results and Provides Corporate Update

Opiant Pharmaceuticals (NASDAQ:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions, today reported financial results for the first quarter...